rldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which market its medicines in over 100 countries.

Learn more atwww.ferring.com, or connect with us onLinkedIn,Instagram,YouTube,FacebookandX.

About Rebyota®
Rebyota is a pre-packaged, single-dose 150 mL microbiota suspension for rectal administration consisting of a liquid mix of up to trillions of live microbes – includingBacteroides. Rebyota is delivered directly to the gut microbiome and is administered by a healthcare professional in one visit.

Indication
Rebyota®(faecal microbiota, live – jslm) is indicated for the prevention of recurrence ofClostridioides difficile(C. diff)infection in individuals 18 years of age and older, following antibiotic treatment for recurrentC. diffinfection.

Limitation of Use
Rebyota is not indicated for the treatment ofC. diffinfection.

Important S
=*=*=*=*=*=
当前为第3/5页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页